TRAW vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

TRAW

34.2
AI Score
VS
CLYM Wins

CLYM

63.6
AI Score

Investment Advisor Scores

TRAW

34score
Recommendation
SELL

CLYM

64score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TRAW CLYM Winner
Net Income 9.17M -27.22M TRAW
Operating Income -17.88M -30.57M TRAW
ROE -1457.9% -11.4% CLYM
ROA 86.4% -11.1% TRAW
Total Assets 10.62M 246.29M CLYM
Current Ratio 0.72 31.45 CLYM

Relative Price Performance (Last 90 Days)

TRAW 1M: -1.3% · 3M: -30.9% CLYM 1M: -21.4% · 3M: -12.2%

Current Technical Phase

TRAW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $0.58

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.9 · Price: $11.45

Fundamentals Snapshot

Metric TRAW CLYM
Market Cap — —
Forward P/E -0.3 -11.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.83 -0.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.